Ledger.
Investor · Cambridge, MA

Mark G. Currie

Open Mark in the network graph →
Filings
20
SEC Form D
Connections
64
co-filers
Capital
$3.2M
across filings
Active
Feb 2020
to May 2025

Most-connected co-filers (64)

James P. Pearson · Cambridge, MA10 sharedShaker J. Sadasivam · Cambridge, MA9 sharedJosh G. Israel · Boston, MA7 sharedWalter K. Brown · Cambridge, MA7 sharedNabil J. Elkouh · Cambridge, MA7 sharedEric R. Olson · Cambridge, MA7 sharedPatrik N. Burnas · Luxembourg, Luxembourg7 sharedMichael J. Higgins · Cambridge, MA6 sharedUrsula E. Ungaro · Miami, FL5 sharedMagnus P. Sjocrona · Stockholm, V75 sharedKhoso E. Baluch · Miami, FL5 sharedPaul M. Lehr · Miami, FL5 sharedNataliya A. Agafonova · Miami, FL5 sharedNeil E. Hare · Miami, FL5 sharedWa'El Hashad · Miami, FL5 sharedJoshua M. Hare · Miami, FL5 sharedRock E. Soffer · Miami, FL5 sharedLisa A. Locklear · Miami, FL5 sharedDouglas E. Losordo · Miami, FL4 sharedKamran Ata · Alpharetta, GA3 sharedWayne Geffen · New York, NY3 sharedPawel Zolnierczyk · Skillman, NJ3 sharedBlake Geffen · New York, NY3 sharedJeffrey E. Pfeffer · Miami, FL3 shared

Recent filings (20)

Vivrelle, Inc.Jun 2025 · 14 co-filers$14.5MSea Pharmaceuticals, LLCFeb 2025 · 20 co-filers$2.2MSea Pharmaceuticals, LLCFeb 2025 · 20 co-filers$2.2MLongeveron Inc.Jul 2024 · 33 co-filers$9.5MLongeveron Inc.Jun 2024 · 32 co-filers$9.4MLongeveron Inc.Apr 2024 · 35 co-filers$12.4MLongeveron Inc.Jan 2024 · 35 co-filers$2.6MLongeveron Inc.Oct 2023 · 35 co-filers$8.4MSea Pharmaceuticals, LLCOct 2023 · 22 co-filers$2.2MSea Pharmaceuticals, LLCOct 2023 · 22 co-filers$2.2MVivrelle, Inc.Jul 2022 · 11 co-filers$10.0MFacible BioDiagnostics, Inc.May 2022 · 20 co-filers$1.8MVivrelle, Inc.May 2022 · 7 co-filersFacible BioDiagnostics, Inc.May 2022 · 20 co-filers$2.8M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Mark in the interactive graph →